Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis. Issue 4 (August 2017)

• Record Type: Journal Article
• Authors: Zu'bi, F.; Sidler, M.; Harvey, E.; Lopes, R.I.; Hojjat, Asal; Naoum, N.; Pokarowski, M.; Lorenzo, A.J.; Farhat, W.A.; Papanikolaou, F.; Dos Santos, J.
• Is Part Of: Journal of pediatric urology. Volume 13:Issue 4(2017)
• Page Start: 357.e1
• Page End: 357.e7
• Publication Date: 2017-08
• Subjects: Urinary stones -- Metabolic study -- Risk -- Stone burden -- Children -- Stone growth; Pediatric urology -- Periodicals; Urologic Diseases -- Periodicals; Urogenital Diseases -- Periodicals; Urologic Surgical Procedures -- Periodicals; Child; Infant; Urologie pédiatrique -- Périodiques; Appareil urinaire -- Maladies -- Périodiques; Pédiatrie; Urologie; Pediatric urology; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); Electronic journals; Periodicals; Electronic journals; 618.926
• DOI: 10.1016/j.jpurol.2017.06.022
• Languages: English
• ISSNs: 1477-5131

Abstract

Summary: Introduction: Hypercalciuria, hypocitraturia and cystinuria are the most common underlying metabolic stone abnormalities in children. The present study compared stone growth patterns, stone burden, and the risk of stone-related surgery among these underlying metabolic conditions. Methods: A retrospective cohort of 356 children with renal stones, followed from 2000 to 2015, was studied. Differences among metabolic groups were determined using Kruskal–Wallis test; the Scheffé-test was used for multiple comparisons to determine differences among single groups. Independent sample t -test was used when adequate, given the sample size, and Chi-squared test was used for categorical variables. Stone growth rates were calculated as differences in diameter divided by time elapsed between U/Ss (mm/year). Logistic regression was performed to assess the effect of initial stone size on the likelihood of surgery. Results: Median stone size at presentation was significantly different among groups, with cystinuria being the group with the largest proportion of stones >10 mm, while patients with stones <5 mm were likely to have a normal metabolic workup ( P < 0.05). Stones with a higher growth rate were found in the operative group, while slower growing stones were mostly managed conservatively (3.4 mm/year vs 0.8 mm/year, respectively; P = 0.014). However, stone growth rates were not significantly different among metabolic groups. On the other hand, the rate of new stone formation in cystinuric patients at their first follow-up was 30.4%, which was significantly higher than in patients with hypercalciuria (16.3%) or with a normal metabolic workup (17.2%; P < 0.05). Compared with stones <5 mm, stones measuring 5–10 mm were more than four times more likely to result in surgery, whereas the likelihood of surgery for 10–20 mm or >20 mm stones was almost 16 or 34 times, respectively ( P < 0.001). Conclusions: It is believed that this is the first study to evaluate stone growth patterns, stone burden and surgical risk among children with hypercalciuria, hypocitraturia and cystinuria. Cystinuric patients presented with larger stones at the time of diagnosis, higher new stone formation rates, and were at higher risk of surgery. While no significant difference of growth rate was found among metabolic groups, stones with a higher growth rate were significantly more likely to result in surgical treatment than slower growing stones. Initial stone size, location of largest stone, previous urinary tract infection, and patient's metabolic type significantly influenced the likelihood of a surgical intervention. Better understanding of the natural history ultimately helps surgeons and clinicians defining prognosis, treatment, and prevention plans for pediatric urolithiasis. Summary table Stone-characteristics of metabolic groups. Metabolic type ( N of patients) Normal (126) Hypercalciuria (86) Hypocitraturia (20) Cystinuria (24) Median initial stone size (IQR, mm)* 6.0* (4.0–10.5) 7.0 (5.0–11.5) 6.0 (2.7–10.8) 10.0* (6.0–14.0) Median stone growth rate (IQR, mm/year) a 0.30 (0.0–2.40) 0.15 (0.00–1.90) 0.0 (0.0–0.20) 1.1.41 (0–6.57) % of new stone formation from baseline to first follow-up# 17.2% 16.3% 11.1% 30.4%# *Cystinuric patients had the highest ratio of stones >10 mm, while patients with stones <5 mm were most likely to have a normal metabolic workup ( P < 0.05, Chi-squared test with Bonferroni correction). Moreover, metabolic groups were significantly different from each other, while pairwise comparison did not reach statistical significance. #Cystinuric patients had significantly higher rate of new stone formation compared to other metabolic groups ( P < 0.05, Chi-squared test with Bonferroni correction). a Difference in median stone growth rate was not significantly different across metabolic groups (Kruskal–Wallis test).